1 |
Riboflavin
| 1件: Riboflavin Riboflavin | 2件: Riboflavin Riboflavin; Vitamin B2; | - | - | 8件: 13 13, 38, 46, 96, 97, 162, 168, 265 |
2 |
Resorcinol
| - | 0件: | - | - | - |
3 |
Reserpine
| - | 0件: | - | - | - |
4 |
Rescinnamine
| - | 0件: | - | - | - |
5 |
Rifampin
| 1件: Rifampicin Rifampicin | 2件: RIFAMPICIN RIFAMPICIN; Rifampin; | - | - | 9件: 6 6, 13, 17, 46, 84, 86, 93, 299, 338 |
6 |
Ramipril
| 1件: Ramipril Ramipril | 1件: RAMIPRIL RAMIPRIL; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 46 46, 49, 66, 67, 113, 218, 257 |
7 |
Ranitidine
| 1件: Ranitidine Ranitidine | 1件: Ranitidine Ranitidine; | 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 65 |
8 |
Ribavirin
| 1件: Ribavirin Ribavirin | 2件: Copegus Copegus; Ribavirin; | - | - | 2件: 2 2, 96 |
9 |
Rifabutin
| 1件: Rifabutin Rifabutin | 1件: RIFABUTIN RIFABUTIN; | - | - | 1件: 96 96 |
10 |
Risperidone
| 1件: Risperidone Risperidone | 1件: Risperidone Risperidone; | 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 5件: 8 8, 156, 179, 187, 206 |
11 |
Ritonavir
| 1件: Ritonavir Ritonavir | 2件: Norvir Norvir; Ritonavir; | - | - | 3件: 2 2, 86, 265 |
12 |
Rofecoxib
| 1件: Rofecoxib Rofecoxib | 1件: Rofecoxib Rofecoxib; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
13 |
Repaglinide
| 1件: Repaglinide Repaglinide | 1件: Repaglinide Repaglinide; | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 3件: 6 6, 21, 299 |
14 |
Rosiglitazone maleate
| 1件: Rosiglitazone Rosiglitazone | 2件: Rosiglitazone Rosiglitazone; Rosiglitazone maleate; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 75, 97, 222, 265 |
15 |
Ranitidine hydrochloride
| 1件: Ranitidine Ranitidine | 1件: Ranitidine Ranitidine; | 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 65 |
16 |
Rizatriptan benzoate
| - | 0件: | - | - | - |
17 |
Rabeprazole sodium
| 1件: Rabeprazole Rabeprazole | 1件: Rabeprazole Rabeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 2 2, 51 |
18 |
Rocuronium bromide
| 1件: Rocuronium Rocuronium | 1件: Rocuronium Rocuronium; | 16件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4 💬 | 15件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 296 296 |
19 |
Riluzole
| 1件: Riluzole Riluzole | 2件: Rilutek Rilutek; Riluzole; | 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
20 |
Ropinirole hydrochloride
| 1件: Ropinirole Ropinirole | 3件: REQUIP REQUIP; ROPINIROLE; Ropinirole Hydrochloride; | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 2 2, 6, 74, 309 |
21 |
Rifapentine
| - | 0件: | - | - | - |
22 |
Rimantadine hydrochloride
| - | 0件: | - | - | - |
23 |
Risedronate sodium
| 1件: Risedronic acid Risedronic acid | 3件: Risedronate Risedronate; RISEDRONATE SODIUM; Risedronic acid; | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 9件: 46 46, 50, 66, 93, 95, 96, 107, 113, 274 |
24 |
Raltitrexed
| - | 0件: | - | - | - |
25 |
Rebamipide
| 1件: Rebamipide Rebamipide | 1件: Rebamipide Rebamipide; | - | - | 4件: 46 46, 53, 97, 271 |
26 |
Ramatroban
| 1件: Ramatroban Ramatroban | 1件: Ramatroban Ramatroban; | 2件: PTGDR PTGDR, TBXA2R 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | 1件: 13 13 |
27 |
Remifentanil hydrochloride
| 1件: Remifentanil Remifentanil | 2件: Remifentanil Remifentanil; Remifentanyl; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 70 |
28 |
Ritodrine hydrochloride
| - | 0件: | - | - | - |
29 |
Riboflavin sodium phosphate
| 1件: Riboflavin Riboflavin | 2件: RIBOFLAVIN RIBOFLAVIN; Vitamin B2; | - | - | 8件: 13 13, 38, 46, 96, 97, 162, 168, 265 |
30 |
Roxithromycin
| 1件: Roxithromycin Roxithromycin | 1件: Roxithromycin Roxithromycin; | - | - | 2件: 46 46, 299 |
31 |
Ranimustine
| - | 0件: | - | - | - |
32 |
Rolipram
| 1件: Rolipram Rolipram | 1件: Rolipram Rolipram; | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 8 8, 13 |
33 |
Rokitamycin
| - | 0件: | - | - | - |
34 |
Riboflavin butyrate
| 1件: Riboflavin Riboflavin | 2件: Riboflavin Riboflavin; Vitamin B2; | - | - | 8件: 13 13, 38, 46, 96, 97, 162, 168, 265 |
35 |
Rosuvastatin calcium
| 1件: Rosuvastatin Rosuvastatin | 3件: Crestor Crestor; Rosuvastatin; ROSUVASTATIN CALCIUM; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
36 |
Reglitazar
| - | 0件: | - | - | - |
37 |
Raloxifene hydrochloride
| 1件: Raloxifene Raloxifene | 2件: Raloxifene Raloxifene; Raloxifene hydrochloride; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 46 46 |
38 |
Rolitetracycline
| - | 0件: | - | - | - |
39 |
Rosoxacin
| - | 0件: | - | - | - |
40 |
Ritodrine
| - | 0件: | - | - | - |
41 |
Resorcinol monoacetate
| - | 0件: | - | - | - |
42 |
Rufloxacin
| - | 0件: | - | - | - |
43 |
Rifamycin
| - | 0件: | - | - | - |
44 |
Rifalazil
| - | 0件: | - | - | - |
45 |
Rifaximin
| 1件: Rifaximin Rifaximin | 3件: Rifaximin Rifaximin; RIFAXIMINA; Xifaxan; | - | - | 8件: 6 6, 65, 93, 94, 96, 97, 99, 296 |
46 |
Ravuconazole
| - | 0件: | - | - | - |
47 |
Rivastigmine tartrate
| 1件: Rivastigmine Rivastigmine | 3件: Exelon Exelon; Rivastigmine; Rivastigmine Transdermal System; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 5 5, 6, 13 |
48 |
Rasagiline mesylate
| 1件: Rasagiline Rasagiline | 4件: AZILECT AZILECT; Rasagilina; RASAGILINE; RASAGILINE MESYLATE; | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 2 2, 5, 6, 13, 17, 58, 66 |
49 |
Reboxetine mesylate
| - | 0件: | - | - | - |
50 |
Remoxipride
| - | 0件: | - | - | - |
51 |
Remoxipride hydrochloride
| - | 0件: | - | - | - |
52 |
Ramelteon
| 1件: Ramelteon Ramelteon | 2件: Ramelteon Ramelteon; ROZEREM; | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 8, 46 |
53 |
Rimabotulinumtoxin B
| 1件: Botulinum toxin type B Botulinum toxin type B | 3件: Botulinum toxin type B Botulinum toxin type B; NEUROBLOC; RimabotulinumtoxinB; | 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 2 2, 6, 13, 51 |
54 |
Rituximab
| 1件: Rituximab Rituximab | 6件: MabThera MabThera; Rituxan; Rituximab; Rixathon; Ruxience; TRUXIMA; | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
55 |
Rebimastat
| - | 0件: | - | - | - |
56 |
Rivastigmine
| 1件: Rivastigmine Rivastigmine | 3件: EXELON EXELON; Rivastigmine; Rivastigmine Transdermal System; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 5 5, 6, 13 |
57 |
Rubitecan
| - | 0件: | - | - | - |
58 |
Ropivacaine hydrochloride
| 1件: Ropivacaine Ropivacaine | 1件: Ropivacaine Ropivacaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 36 36, 46, 70 |
59 |
Racemethionine
| 1件: Methionine Methionine | 3件: Butanoic acid Butanoic acid; L-methionine; Methionine; | - | - | 7件: 34 34, 75, 84, 93, 229, 298, 300 |
60 |
Racepinephrine
| - | 0件: | - | - | - |
61 |
Raluridine
| - | 0件: | - | - | - |
62 |
Ramoplanin
| - | 0件: | - | - | - |
63 |
Ranibizumab
| 1件: Ranibizumab Ranibizumab | 3件: Lucentis Lucentis; Ranibizumab; RhuFab V2; | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 4件: 34 34, 166, 227, 301 |
64 |
Ranolazine
| 1件: Ranolazine Ranolazine | 3件: RANEXA RANEXA; Ranolazina; Ranolazine; | - | - | 6件: 2 2, 58, 86, 96, 113, 114 |
65 |
Ranolazine hydrochloride
| 1件: Ranolazine Ranolazine | 3件: RANEXA RANEXA; Ranolazina; Ranolazine; | - | - | 6件: 2 2, 58, 86, 96, 113, 114 |
66 |
Ranpirnase
| - | 0件: | - | - | - |
67 |
Rasburicase
| - | 0件: | - | - | - |
68 |
Raxibacumab
| - | 0件: | - | - | - |
69 |
Regadenoson
| 1件: Regadenoson Regadenoson | 1件: Regadenoson Regadenoson; | 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 58 58 |
70 |
Regramostim
| 1件: Regramostim Regramostim | 2件: GM-CSF GM-CSF; RhGM-CSF; | 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
71 |
Repifermin
| - | 0件: | - | - | - |
72 |
Retapamulin
| - | 0件: | - | - | - |
73 |
Reteplase
| - | 0件: | - | - | - |
74 |
Riboprine
| - | 0件: | - | - | - |
75 |
Ridogrel
| - | 0件: | - | - | - |
76 |
Rilapladib
| - | 0件: | - | - | - |
77 |
Rimexolone
| - | 0件: | - | - | - |
78 |
Rimonabant
| 1件: Rimonabant Rimonabant | 2件: Acomplia Acomplia; Rimonabant; | 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 |
79 |
Ritanserin
| - | 0件: | - | - | - |
80 |
Rivoglitazone
| - | 0件: | - | - | - |
81 |
Rizatriptan sulfate
| - | 0件: | - | - | - |
82 |
Roflumilast
| 1件: Roflumilast Roflumilast | 1件: Roflumilast Roflumilast; | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 84 84, 299 |
83 |
Ronnel
| - | 0件: | - | - | - |
84 |
Roquinimex
| - | 0件: | - | - | - |
85 |
Rostaporfin
| - | 0件: | - | - | - |
86 |
Rotigaptide
| - | 0件: | - | - | - |
87 |
Rotigotine
| 1件: Rotigotine Rotigotine | 3件: NEUPRO NEUPRO; ROTIGOTINA; Rotigotine; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 127 |
88 |
Roxarsone
| - | 0件: | - | - | - |
89 |
Rufinamide
| 1件: Rufinamide Rufinamide | 2件: Inovelon Inovelon; RUFINAMIDE; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 144 144 |
90 |
Rupintrivir
| - | 0件: | - | - | - |
91 |
Ruplizumab
| - | 0件: | - | - | - |
92 |
Renzapride
| - | 0件: | - | - | - |
93 |
Ranirestat
| - | 0件: | - | - | - |
94 |
Relacatib
| - | 0件: | - | - | - |
95 |
Rilonacept
| 1件: Rilonacept Rilonacept | 1件: Rilonacept Rilonacept; | 2件: IL1A IL1A, IL1B 💬 | 45件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 4件: 51 51, 106, 107, 266 |
96 |
Romidepsin
| - | 0件: | - | - | - |
97 |
Rusalatide acetate
| - | 0件: | - | - | - |
98 |
Raltegravir
| 1件: Raltegravir Raltegravir | 2件: ISENTRESS ISENTRESS; Raltegravir; | - | - | 4件: 13 13, 26, 93, 265 |
99 |
Rhubarb
| - | 0件: | - | - | - |
100 |
Rosin
| - | 0件: | - | - | - |
101 |
Rociverine
| - | 0件: | - | - | - |
102 |
Rivaroxaban
| 1件: Rivaroxaban Rivaroxaban | 2件: RIVAROXABAN RIVAROXABAN; Xarelto; | 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 5件: 46 46, 49, 75, 91, 210 |
103 |
Ronifibrate
| - | 0件: | - | - | - |
104 |
Ritiometan
| - | 0件: | - | - | - |
105 |
Rupatadine
| 1件: Rupatadine Rupatadine | 1件: Rupatadine Rupatadine; | 2件: HRH1 HRH1, PTAFR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 46 46 |
106 |
Rabeprazole
| 1件: Rabeprazole Rabeprazole | 1件: Rabeprazole Rabeprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 2 2, 51 |
107 |
Racecadotril
| - | 0件: | - | - | - |
108 |
Raloxifene
| 1件: Raloxifene Raloxifene | 2件: Raloxifene Raloxifene; Raloxifene hydrochloride; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 46 46 |
109 |
Ramosetron
| - | 0件: | - | - | - |
110 |
Rasagiline
| 1件: Rasagiline Rasagiline | 4件: Azilect Azilect; Rasagilina; Rasagiline; RASAGILINE MESYLATE; | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 2 2, 5, 6, 13, 17, 58, 66 |
111 |
Raubasine
| - | 0件: | - | - | - |
112 |
Reboxetine
| - | 0件: | - | - | - |
113 |
Remifentanil
| 1件: Remifentanil Remifentanil | 2件: Remifentanil Remifentanil; Remifentanyl; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 70 |
114 |
Reproterol
| - | 0件: | - | - | - |
115 |
Ribostamycin
| - | 0件: | - | - | - |
116 |
Rilmenidine
| 1件: Rilmenidine Rilmenidine | 2件: HYPERIUM HYPERIUM; Rilmenidine; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 8 8 |
117 |
Rimantadine
| - | 0件: | - | - | - |
118 |
Risedronic acid
| 1件: Risedronic acid Risedronic acid | 3件: Risedronate Risedronate; RISEDRONATE SODIUM; Risedronic acid; | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 9件: 46 46, 50, 66, 93, 95, 96, 107, 113, 274 |
119 |
Rizatriptan
| - | 0件: | - | - | - |
120 |
Robenidine
| - | 0件: | - | - | - |
121 |
Romifidine
| - | 0件: | - | - | - |
122 |
Ropinirole
| 1件: Ropinirole Ropinirole | 3件: REQUIP REQUIP; ROPINIROLE; Ropinirole Hydrochloride; | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 2 2, 6, 74, 309 |
123 |
Ropivacaine
| 1件: Ropivacaine Ropivacaine | 1件: Ropivacaine Ropivacaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 36 36, 46, 70 |
124 |
Rosiglitazone
| 1件: Rosiglitazone Rosiglitazone | 2件: Rosiglitazone Rosiglitazone; Rosiglitazone maleate; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 75, 97, 222, 265 |
125 |
Rosuvastatin
| 1件: Rosuvastatin Rosuvastatin | 3件: Crestor Crestor; Rosuvastatin; ROSUVASTATIN CALCIUM; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
126 |
Roxatidine acetate
| - | 0件: | - | - | - |
127 |
Ruscogenin
| - | 0件: | - | - | - |
128 |
Rutoside
| - | 0件: | - | - | - |
129 |
Ridaforolimus
| - | 0件: | - | - | - |
130 |
Reparixin
| 1件: Reparixin Reparixin | 1件: Reparixin Reparixin; | 2件: CXCR1 CXCR1, CXCR2 💬 | 7件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 298 298, 299 |
131 |
Reslizumab
| 1件: Reslizumab Reslizumab | 1件: Reslizumab Reslizumab; | 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 98 |
132 |
Retosiban
| - | 0件: | - | - | - |
133 |
Rolofylline
| - | 0件: | - | - | - |
134 |
Romiplostim
| 1件: Romiplostim Romiplostim | 2件: NPLATE NPLATE; Romiplostim; | 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 4件: 60 60, 63, 64, 65 |
135 |
Ropidoxuridine
| - | 0件: | - | - | - |
136 |
Remikiren
| - | 0件: | - | - | - |
137 |
Raspberry
| 1件: Raspberry Raspberry | 1件: Raspberry Raspberry; | - | - | 1件: 97 97 |
138 |
Radezolid
| - | 0件: | - | - | - |
139 |
Ramucirumab
| - | 0件: | - | - | - |
140 |
Retaspimycin
| - | 0件: | - | - | - |
141 |
Riociguat
| 1件: Riociguat Riociguat | 2件: Adempas Adempas; RIOCIGUAT; | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 6件: 51 51, 84, 86, 88, 225, 299 |
142 |
Razupenem
| - | 0件: | - | - | - |
143 |
Rilotumumab
| - | 0件: | - | - | - |
144 |
Rindopepimut
| - | 0件: | - | - | - |
145 |
Rintatolimod
| - | 0件: | - | - | - |
146 |
Rontalizumab
| 1件: Rontalizumab Rontalizumab | 1件: Rontalizumab Rontalizumab; | 13件: IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | 25件: Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 49 49 |
147 |
Rozrolimupab
| - | 0件: | - | - | - |
148 |
Remestemcel-L
| 1件: Remestemcel-L Remestemcel-L | 3件: Adult human mesenchymal stem cells Adult human mesenchymal stem cells; Prochymal; Remestemcel-L; | - | - | 3件: 85 85, 96, 97 |
149 |
Rilpivirine
| - | 0件: | - | - | - |
150 |
Riferminogene pecaplasmid
| - | 0件: | - | - | - |
151 |
Royal jelly
| 1件: Royal jelly Royal jelly | 1件: Royal jelly Royal jelly; | - | - | 1件: 49 49 |
152 |
Rezatomidine
| - | 0件: | - | - | - |
153 |
Ruxolitinib
| 1件: Ruxolitinib Ruxolitinib | 1件: Ruxolitinib Ruxolitinib; | 2件: JAK1 JAK1, JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 228 228 |
154 |
Remogliflozin etabonate
| - | 0件: | - | - | - |
155 |
Robatumumab
| - | 0件: | - | - | - |
156 |
Rucaparib
| - | 0件: | - | - | - |
157 |
Regorafenib
| - | 0件: | - | - | - |
158 |
Radavirsen
| - | 0件: | - | - | - |
159 |
Rigosertib
| 1件: Rigosertib Rigosertib | 1件: Rigosertib Rigosertib; | 1件: PLK1 PLK1 💬 | 4件: Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 36 36 |
160 |
Romosozumab
| 1件: Romosozumab Romosozumab | 2件: Evenity Evenity; ROMOSOZUMAB; | 1件: SOST SOST 💬 | 2件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬 | 1件: 274 274 |
161 |
Rebastinib
| - | 0件: | - | - | - |
162 |
Ramatercept
| - | 0件: | - | - | - |
163 |
Rabusertib
| - | 0件: | - | - | - |
164 |
Radium Ra 223 dichloride
| - | 0件: | - | - | - |
165 |
Rivipansel
| - | 0件: | - | - | - |
166 |
Roxadustat
| - | 0件: | - | - | - |
167 |
Ralimetinib
| - | 0件: | - | - | - |
168 |
Relamorelin
| - | 0件: | - | - | - |
169 |
Ricolinostat
| - | 0件: | - | - | - |
170 |
Rimegepant
| - | 0件: | - | - | - |
171 |
Rabacfosadine
| - | 0件: | - | - | - |
172 |
Ralinepag
| 1件: Ralinepag Ralinepag | 1件: RALINEPAG RALINEPAG; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
173 |
Relebactam
| - | 0件: | - | - | - |
174 |
Rolapitant
| - | 0件: | - | - | - |
175 |
Rurioctocog alfa pegol
| 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol; | - | - | 1件: 288 288 |
176 |
Rasagiline tartrate
| 1件: Rasagiline Rasagiline | 4件: Azilect Azilect; Rasagilina; Rasagiline; RASAGILINE MESYLATE; | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 2 2, 5, 6, 13, 17, 58, 66 |
177 |
Rociletinib
| - | 0件: | - | - | - |
178 |
Ribociclib
| - | 0件: | - | - | - |
179 |
Relugolix
| - | 0件: | - | - | - |
180 |
Recanaclotide
| - | 0件: | - | - | - |
181 |
Remetinostat
| - | 0件: | - | - | - |
182 |
Revefenacin
| - | 0件: | - | - | - |
183 |
Rovalpituzumab tesirine
| - | 0件: | - | - | - |
184 |
Ropeginterferon alfa-2b
| - | 0件: | - | - | - |
185 |
Risankizumab
| 1件: Risankizumab Risankizumab | 1件: Risankizumab Risankizumab; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 4件: 37 37, 96, 97, 271 |
186 |
Ravulizumab
| 1件: Ravulizumab Ravulizumab | 2件: RAVULIZUMAB RAVULIZUMAB; Ultomiris; | 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 |
187 |
Rimiducid
| 1件: Rimiducid Rimiducid | 1件: Rimiducid Rimiducid; | 1件: CASP9 CASP9 💬 | 35件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | 6件: 19 19, 60, 65, 284, 285, 326 |
188 |
Ribaxamase
| - | 0件: | - | - | - |
189 |
Rezafungin
| - | 0件: | - | - | - |
190 |
Ruzasvir
| - | 0件: | - | - | - |
191 |
Relenopride
| - | 0件: | - | - | - |
192 |
Roluperidone
| - | 0件: | - | - | - |
193 |
Reltecimod
| - | 0件: | - | - | - |
194 |
Ravoxertinib
| - | 0件: | - | - | - |
195 |
Rivoceranib
| - | 0件: | - | - | - |
196 |
Reproxalap
| 1件: Reproxalap Reproxalap | 1件: Reproxalap Reproxalap; | - | - | 1件: 160 160 |
197 |
Rovazolac
| - | 0件: | - | - | - |
198 |
Relacorilant
| 1件: Relacorilant Relacorilant | 2件: CORT125134 CORT125134; Relacorilant; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
199 |
Relatlimab
| - | 0件: | - | - | - |
200 |
Ripretinib
| - | 0件: | - | - | - |
201 |
Reldesemtiv
| 1件: Reldesemtiv Reldesemtiv | 2件: CK-2127107 CK-2127107; RELDESEMTIV; | 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 2件: 2 2, 3 |
202 |
Risdiplam
| 1件: Risdiplam Risdiplam | 2件: EVRYSDI EVRYSDI; Risdiplam; | 1件: SMN2 SMN2 💬 | 1件: Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | 1件: 3 3 |
203 |
Risuteganib
| - | 0件: | - | - | - |
204 |
Remdesivir
| - | 0件: | - | - | - |
205 |
Razuprotafib
| - | 0件: | - | - | - |
206 |
Ravagalimab
| 1件: Ravagalimab Ravagalimab | 1件: RAVAGALIMAB RAVAGALIMAB; | 1件: CD40 CD40 💬 | 17件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | 2件: 53 53, 97 |
207 |
Romilkimab
| - | 0件: | - | - | - |
208 |
Racemetyrosine
| - | 0件: | - | - | - |
209 |
Rovafovir etalafenamide
| - | 0件: | - | - | - |
210 |
Remimazolam
| - | 0件: | - | - | - |
211 |
Retifanlimab
| - | 0件: | - | - | - |
212 |
Rimtuzalcap
| - | 0件: | - | - | - |
213 |
Ridinilazole
| - | 0件: | - | - | - |
214 |
Rozanolixizumab
| 1件: Rozanolixizumab Rozanolixizumab | 1件: ROZANOLIXIZUMAB ROZANOLIXIZUMAB; | 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 |
215 |
Regdanvimab
| - | 0件: | - | - | - |